Tag: Department of Pharmaceuticals

The Department of Pharmaceuticals (DoP) has called for applications from eligible medical device firms for the newly created Category B of the...

The Department of Pharmaceuticals (DoP) has extended an invitation to eligible active pharmaceutical ingredient (API) manufacturers in the country to apply for...

The Department of Pharmaceuticals (DoP) is planning to roll out a series of initiatives under the banner of Schemes for "Strengthening Pharmaceuticals...

The SME Pharma Industries-Confederation (SPIC), a body of thousands of small-scale pharma units in the country, has appealed to the department of...

The Department of Pharmaceuticals (DoP) has revised the list of medical devices for which the government and public sector procurers could not...

The Department of Pharmaceuticals (DoP) has extended the deadline for submission of application for the production linked incentive (PLI) scheme for pharmaceuticals...

The Department of Pharmaceuticals (DoP) is in the process of compiling and publishing a list of Frequently Asked Questions (FAQs) based on...

The Department of Pharmaceuticals, with an objective to attain self-reliance and reduce import dependence in critical Bulk Drugs - Key Starting Materials...

The Department of Pharmaceuticals (DoP) has issued revised guidelines under the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical...

In view of the "acute shortage" of Tocilizumab which is prescribed to a large number of C-19 patients, the Delhi High Court has directed the Union Health...

As C-19 cases surge in the country , the government of India on Sunday ordered prohibition on the export of Remdesivir drug...

The Department of Pharmaceuticals (DoP) has incorporated 19 medical devices in the revised guidelines of the public procurement policy. The revised order...

In May 2013, the Department of Pharmaceuticals (DoP) of India brought 348 medicines— essential and lifesaving drugs from the National List of Essential Medicines (NLEM)—under price control by...

Total outstanding amount of Rs. 8,200 crore related to 880 overcharging cases of Drug Prices Control Order (DPCO) violations are pending with...

The Department of Pharmaceuticals (DoP) has prepared a phased manufacturing programme (PMP) in consultation with department of revenue (DoR) to promote domestic...

The Union environment ministry has finally issued environmental clearance for active pharmaceutical ingredients (APIs) and intermediates as single category instead of individual...

New Delhi: Highlighting the need for strong indigenous pharma companies, a Parliamentary panel has recommended that the pharma industry should be categorised as a "strategic sector"...

The Department of Pharmaceuticals (DoP) has proposed draft framework of Special One-Time Settlement (SOTS) scheme to pharma companies for fast track recovery...

PLI Scheme for Intermediates and APIs approved The Applications of following companies, which have committed more than the minimum...

Even as the Department of Pharmaceuticals (DoP) has been seeking compliance reports from industry regarding implementation of the Uniform Code of Pharmaceutical...

Revised guidelines for procurement of drugs The Department of Pharmaceuticals (DoP) recently issued revised guidelines of Public Procurement Order...

The medical devices industry has sought clarity on the Central government’s claim that medical device sector has been adequately covered under the...

The Department of Pharmaceuticals (DoP) has issued revised guidelines for implementing the provisions of public procurement (preference to Make in India) Order...

The Department of Pharmaceutical (DoP) has issued a letter to the pharma industry’s key associations, namely; IDMA, BDMA, IPA, OPPI and FOPE...